Chorioretinal Imaging, Vascular Biomarkers, and Ultra-Trail: A Pilot Study (UTMA-RETINA)
Retinal and choroidal microcirculation is a relevant biomarker of systemic vascular health and lies at the heart of eye-heart interactions. Noninvasive retinal imaging, particularly OCT angiography (OCT-A), now makes it possible to examine retinal and choroidal microvascularization in vivo and to study its relationship with systemic cardiovascular and neurovascular mechanisms.
Ultra-endurance activities, such as ultra-trail races, induce significant systemic hemodynamic changes, including dehydration, variations in perfusion pressure, prolonged sympathetic activation, and redistribution of blood flow. These physiological adaptations could lead to acute and reversible changes in retinal and choroidal vascular parameters as measured by retinophotography and OCT angiography.
Several studies suggest that intense physical exercise may be accompanied by significant changes in retinal and choroidal microvascular perfusion. In particular, a significant decrease in the vascular density of the superficial retinal plexus has been observed following intense exercise in a healthy population, suggesting a transient change in retinal microcirculation. Similarly, following a marathon, a decrease in the retinal vascular density index (RVDI) has been reported, likely related to exercise-induced vasoconstriction and a transient reduction in retinal blood flow. This decrease may also be exacerbated by the drop in systemic blood pressure and the relative dehydration observed after the race. More broadly, intense endurance exercise is accompanied by cardiovascular and neurohormonal adaptations, particularly through activation of the renin-angiotensin-aldosterone system, which may modulate ocular perfusion. Scott et al. demonstrated, following a 160-km ultramarathon, significant alterations in left ventricular function and a major elevation in NT-pro-BNP, indicating systemic cardiovascular stress that was markedly greater than that observed after a standard marathon. Furthermore, a multi-omics study conducted during the Ultra-Trail du Mont-Blanc (171 km) revealed systemic oxidative stress, marked inflammation with elevated IL-6 levels, and profound metabolic changes affecting red blood cells-mechanisms recognized as being involved in microvascular dysfunction. However, these variations primarily reflect functional changes in perfusion related to hemodynamic status and autonomic tone, rather than true structural microvascular remodeling or angiogenesis. Metrics derived from OCT angiography, such as vascular density or perfusion density, are in fact sensitive to systemic variations in circulating volume, perfusion pressure, and the quality of the acquired signal.
In this context, the effects of ultra-endurance exercise on the eye remain poorly characterized. Research in this area is necessary to better understand the acute physiological adaptations of ocular microcirculation and to highlight the value of retinal imaging as a tool for cardiovascular research and prevention within an integrated eye-heart approach.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Louis ARNOULD, Pr
- Numero di telefono: +33 03.80.29.34.53
- Email: Louis.arnould@chu-dijon.fr
Luoghi di studio
-
-
-
Dijon, Francia, 21000
- CHU Dijon Bourgogne
-
Contatto:
- Louis ARNOULD, Pr
- Numero di telefono: +33 03.80.29.34.53
- Email: Louis.arnould@chu-dijon.fr
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Participant who has given free, informed, and verbal consent
- Participant of legal age
- Participant registered for the UTMA 100 km solo ultra-trail race (for the "ultra-trail" group)
- Active subject not exposed to intense physical exertion (>6 hours of exercise) within the 7 days prior to the enrollment visit (for the "active control" group)
- Participant with an estimated physical activity level of 4-6 hours per week (for the "active control" group)
- Participant agreeing to undergo ophthalmological examinations on the same schedule as the ultra-trail group (for the "active control" group)
Exclusion Criteria:
- Myopia > 6 diopters
- Type 1 or Type 2 diabetes
- Protected individuals: Minors, individuals under legal protection (guardianship, conservatorship, court order), individuals unable to give informed consent
- Individuals not enrolled in a social security program
- Pregnant or breastfeeding women
- Participants with a systemic or inflammatory vascular condition and cardiovascular risk
- Participants with an ocular condition or ophthalmological history likely to impair retinal/choroidal microcirculation or the quality of imaging (vascular and degenerative macular conditions, cataracts)
- Participants being treated with vasoconstrictors
- Tobacco use within 4 hours prior to enrollment
- Caffeine consumption within 1 hour prior to enrollment
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Non randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Altro: Participants who ran the 100-km ultra trail
|
Retinal imaging evaluation of both eyes without dilation before and after the Mont Afrique Ultra Trail
|
|
Altro: Active controls who were not exposed to intense physical exertion within the past 7 days
|
Retinal imaging evaluation of both eyes without dilation, performed in two stages (T0 and T0+11/24H)
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Difference in macular vascular density of the superficial capillary plexus between the pre-race and immediate post-race examinations
Lasso di tempo: When measuring vascular biomarkers on Day 1
|
Assessment of the Acute Impact of Ultra-Endurance Exercise on Retinal Microcirculation (vascular density) and choroidal microcirculation (choroidal thickness and choroidal vascular index) by comparing vascular biomarkers measured by OCT angiography in ultra-trail runners before and 15 to 60 minutes after the race.
|
When measuring vascular biomarkers on Day 1
|
Collaboratori e investigatori
Sponsor
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- ARNOULD 2026
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .